It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
A synbiotic containing Lactiplantibacillus plantarum [American Type Culture Collection (ATCC) strain identifier 202195] and fructooligosaccharide was reported to reduce the risk of sepsis in young infants in rural India. Here, the whole genome of two isolates of L. plantarum ATCC 202195, which were deposited to the ATCC approximately 20 years apart, were sequenced and analyzed to verify their taxonomic and strain-level identities, identify potential antimicrobial resistant genes and virulence factors, and identify genetic characteristics that may explain the observed clinical effects of L. plantarum ATCC 202195. Minimum inhibitory concentrations for selected antimicrobial agents were determined using broth dilution and gradient strip diffusion techniques. The two L. plantarum ATCC 202195 isolates were genetically identical with only three high-quality single nucleotides polymorphisms identified, and with an average nucleotide identity of 99.99%. In contrast to previously published reports, this study determined that each isolate contained two putative plasmids. No concerning acquired or transferable antimicrobial resistance genes or virulence factors were identified. Both isolates were sensitive to several clinically important antibiotics including penicillin, ampicillin and gentamicin, but resistant to vancomycin. Genes involved in stress response, cellular adhesion, carbohydrate metabolism and vitamin biosynthesis are consistent with features of probiotic organisms.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details
1 Hospital for Sick Children, Centre for Global Child Health, Toronto, Canada (GRID:grid.42327.30) (ISNI:0000 0004 0473 9646)
2 Hospital for Sick Children, Cell Biology Program, Research Institute, Toronto, Canada (GRID:grid.42327.30) (ISNI:0000 0004 0473 9646)
3 International Flavors & Fragrances Inc., Madison, USA (GRID:grid.471112.0) (ISNI:0000 0001 1017 8476)
4 Child Health Research Foundation, Dhaka, Bangladesh (GRID:grid.466620.0)
5 University of Toronto, Department of Paediatrics, Faculty of Medicine, Toronto, Canada (GRID:grid.17063.33) (ISNI:0000 0001 2157 2938); Hospital for Sick Children, Division of Microbiology, Toronto, Canada (GRID:grid.42327.30) (ISNI:0000 0004 0473 9646)
6 Hospital for Sick Children, Centre for Global Child Health, Toronto, Canada (GRID:grid.42327.30) (ISNI:0000 0004 0473 9646); University of Toronto, Department of Paediatrics, Faculty of Medicine, Toronto, Canada (GRID:grid.17063.33) (ISNI:0000 0001 2157 2938); University of Toronto, Dalla Lana School of Public Health, Toronto, Canada (GRID:grid.17063.33) (ISNI:0000 0001 2157 2938); Hospital for Sick Children, Division of Infectious Diseases, Toronto, Canada (GRID:grid.42327.30) (ISNI:0000 0004 0473 9646)
7 Hospital for Sick Children, Centre for Global Child Health, Toronto, Canada (GRID:grid.42327.30) (ISNI:0000 0004 0473 9646); University of Toronto, Department of Paediatrics, Faculty of Medicine, Toronto, Canada (GRID:grid.17063.33) (ISNI:0000 0001 2157 2938); University of Toronto, Dalla Lana School of Public Health, Toronto, Canada (GRID:grid.17063.33) (ISNI:0000 0001 2157 2938); Hospital for Sick Children, Peter Gilgan Centre for Research and Learning, Paediatric Medicine and Child Health Evaluative Sciences, Toronto, Canada (GRID:grid.42327.30) (ISNI:0000 0004 0473 9646)
8 Hospital for Sick Children, Cell Biology Program, Research Institute, Toronto, Canada (GRID:grid.42327.30) (ISNI:0000 0004 0473 9646); University of Toronto, Department of Paediatrics, Faculty of Medicine, Toronto, Canada (GRID:grid.17063.33) (ISNI:0000 0001 2157 2938); Hospital for Sick Children, Gastroenterology, Hepatology and Nutrition, Toronto, Canada (GRID:grid.42327.30) (ISNI:0000 0004 0473 9646)